Xiaodong Wang, a Director at BeOne Medicines Ltd. (ONC), sold 14,525 shares of the company's stock on September 30, 2026. The transactions were executed at an average price of $366.58 per share, resulting in a total value of approximately $5.32 million.
This sale follows a series of other transactions by Mr. Wang on September 28, 2026, which involved the sale of an additional 7,847 shares across multiple trades, totaling over $2.89 million. Insider sales can be driven by various factors, including portfolio diversification, tax obligations, or pre-arranged trading plans, and do not necessarily reflect a negative outlook on the company's future performance.